Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

BLFS Quotes by TradingView

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 317,716 shares of BLFS, which is worth approximately $7.43 Million. The most recent transaction as insider was on Sep 29, 2022, when has been sold 657 shares (Common Stock) at a price of $23.02 per share, resulting in proceeds of $15,124. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 318K
0.14% 3M change
15.56% 12M change
Total Value Held $7.43 Million

Aby J. Mathew Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 29 2022
SELL
Open market or private sale
$15,124 $23.02 p/Share
657 Reduced 0.26%
254,081 Common Stock
Aug 31 2022
SELL
Open market or private sale
$9,962 $23.44 p/Share
425 Reduced 0.17%
254,738 Common Stock
Aug 14 2022
BUY
Grant, award, or other acquisition
-
411 Added 0.16%
255,163 Common Stock
Aug 10 2022
SELL
Open market or private sale
$2,595 $23.17 p/Share
112 Reduced 0.04%
254,752 Common Stock
Jul 29 2022
BUY
Grant, award, or other acquisition
-
524 Added 0.21%
254,864 Common Stock
Jul 17 2022
BUY
Grant, award, or other acquisition
-
635 Added 0.25%
254,340 Common Stock
Jul 03 2022
BUY
Grant, award, or other acquisition
-
690 Added 0.27%
253,705 Common Stock
Jun 28 2022
SELL
Open market or private sale
$10,461 $14.86 p/Share
704 Reduced 0.28%
253,015 Common Stock
Jun 19 2022
BUY
Grant, award, or other acquisition
-
733 Added 0.29%
253,719 Common Stock
Jun 05 2022
BUY
Grant, award, or other acquisition
-
735 Added 0.29%
252,986 Common Stock
May 27 2022
SELL
Open market or private sale
$5,100 $14.53 p/Share
351 Reduced 0.14%
252,251 Common Stock
May 22 2022
BUY
Grant, award, or other acquisition
-
786 Added 0.31%
252,602 Common Stock
May 13 2022
SELL
Open market or private sale
$1,331 $12.32 p/Share
108 Reduced 0.04%
251,816 Common Stock
Apr 18 2022
SELL
Open market or private sale
$339,927 $17.59 p/Share
19,325 Reduced 7.12%
251,924 Common Stock
Apr 12 2022
BUY
Exercise of conversion of derivative security
-
45,726 Added 14.43%
271,249 Common Stock
Mar 29 2022
SELL
Open market or private sale
$14,634 $22.24 p/Share
658 Reduced 0.29%
225,523 Common Stock
Mar 01 2022
SELL
Open market or private sale
$9,797 $23.78 p/Share
412 Reduced 0.2%
205,152 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
21,029 Added 8.49%
226,593 Common Stock
Feb 10 2022
SELL
Open market or private sale
$13,221 $29.38 p/Share
450 Reduced 0.22%
205,564 Common Stock
Feb 03 2022
SELL
Open market or private sale
$273,075 $27.76 p/Share
9,837 Reduced 4.56%
206,014 Common Stock
Feb 03 2022
BUY
Exercise of conversion of derivative security
$20,264 $2.06 p/Share
9,837 Added 4.36%
215,851 Common Stock
Feb 02 2022
SELL
Open market or private sale
$298,800 $29.88 p/Share
10,000 Reduced 4.63%
206,014 Common Stock
Feb 02 2022
BUY
Exercise of conversion of derivative security
$37,000 $3.7 p/Share
10,000 Added 4.42%
216,014 Common Stock
Jan 05 2022
SELL
Open market or private sale
$269,495 $34.3 p/Share
7,857 Reduced 3.67%
206,014 Common Stock
Jan 05 2022
BUY
Exercise of conversion of derivative security
$11,000 $1.4 p/Share
7,857 Added 3.54%
213,871 Common Stock
AJM

Aby J. Mathew

EVP & Chief Scientific Officer
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLFS